Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check14 days agoChange DetectedVersion update to Revision: v3.7.0 is shown, and a large block of terms and fields—such as regulatory status, the study drugs, disease/MeSH terms, and key eligibility/outcome descriptors—were removed from the page. This change alters how the study is described and indexed on ClinicalTrials.gov.SummaryDifference19%

- Check36 days agoChange DetectedRevision label on the page updated from v3.6.5 to v3.6.6, indicating a newer page build.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change does not modify substantive content or functionality.SummaryDifference0.1%

- Check71 days agoChange Detected- Revision updated from v3.6.3 to v3.6.4, indicating a minor site update. The change does not alter study content or user-facing functionality.SummaryDifference0.1%

- Check78 days agoChange DetectedStudy timeline details were updated to show actual dates and enrollment, including a Primary Completion date of 2026-12-30 and a Study Completion date of 2027-12-30. Enrollment is now listed as 14, and the status labels indicate actual milestones rather than estimates.SummaryDifference0.6%

- Check93 days agoChange DetectedThe page now reflects a new Revision: v3.6.3, replacing the previous v3.6.2 revision. This is a metadata update indicating a released update to the page content without altering substantive information.SummaryDifference0.1%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.